APA (7th ed.) Citation

Pahwa, R., Dubhashi, J., Singh, A., Jailwala, P., Lobanov, A., Thomas, C. J., . . . Srinivasan, R. (2022). Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma. Journal of Experimental & Clinical Cancer Research, 41(1), . https://doi.org/10.1186/s13046-022-02416-z

Chicago Style (17th ed.) Citation

Pahwa, Roma, et al. "Inhibition of HSP 90 Is Associated with Potent Anti-tumor Activity in Papillary Renal Cell Carcinoma." Journal of Experimental & Clinical Cancer Research 41, no. 1 (2022). https://doi.org/10.1186/s13046-022-02416-z.

MLA (9th ed.) Citation

Pahwa, Roma, et al. "Inhibition of HSP 90 Is Associated with Potent Anti-tumor Activity in Papillary Renal Cell Carcinoma." Journal of Experimental & Clinical Cancer Research, vol. 41, no. 1, 2022, https://doi.org/10.1186/s13046-022-02416-z.

Warning: These citations may not always be 100% accurate.